Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162734 Inhibiting interaction of antisense nucleotides with jun-N-terminal kinases (JNKs) via administering 4-(4-fluoro-phenyl)-2-(4-methlysulfinylphenyl)-5-(4-pyridyl)-1H-imidazole; stem cells
08/28/2003US20030162725 Comprises 5-hydroxytryptophan (for enhancing serotonin-mediated neurotransmission), vitamin B6, epigallocatechin gallate (EGCG, for enhancing thermogenesis), caffeine, and anorectic agents
08/28/2003US20030162724 Such as tris(4-(N-alpha-(2-(1H-indol-3-yl)acetyl)-L-lysyl)aminophenyl)methane hydrochloride for treatment of thrombocytopenia
08/28/2003US20030162723 Supplementation of equine feedstuffs
08/28/2003US20030162721 Anticancer agents; bioavailability; sustained release
08/28/2003US20030162720 Therapeutic anti-HIV (IV9) compounds
08/28/2003US20030162719 Immobilization of active materials
08/28/2003US20030162718 Antigrowth agents; microbiocides, bactericides
08/28/2003US20030162717 Suppression appetite; weight loss therapy
08/28/2003US20030162716 Methods useful in the treatment of bone resorption diseases
08/28/2003US20030162715 Fertility; controlling cell differentiation
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162712 Tek antagonists
08/28/2003US20030162711 Pharmaceutical formulation
08/28/2003US20030162710 Physiologically active polypeptide and DNA
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162708 Saline paste in saline solution; controlling bleeding during surgery
08/28/2003US20030162707 Surgery; reducting inflammation, immunology response
08/28/2003US20030162706 Cardiovascular disorders; rheumatic diseases; antiinflammatory agents; strokes
08/28/2003US20030162705 Liver extract
08/28/2003US20030162704 Method of treatment of parkison's disease with a protein extractable from mammalian organs
08/28/2003US20030162703 Polypeptide antiulcer agents
08/28/2003US20030162702 Compositions and methods for altering cell migration
08/28/2003US20030162700 Central nervous system disorders; antiinflammatory agents; autoimmune disease; leukemia inhibitory factor
08/28/2003US20030162699 Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone
08/28/2003US20030162698 Methods and compositions for treating dopaminergic and gaba-nergic disorders
08/28/2003US20030162697 Tripropeptin antibiotic
08/28/2003US20030162695 Glucocorticoid blocking agents for increasing blood-brain barrier permeability
08/28/2003US20030162694 Novel treatment for pathological aggression
08/28/2003US20030162693 Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
08/28/2003US20030162691 Novel antimicrobial therapies
08/28/2003US20030162289 Peptides promoting cell adherence, growth and secretion
08/28/2003US20030162279 22438, 23553, 25278, and 26212 novel human sulfatases
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162268 Retinoic acid (RA) regulated gene was cloned and expressed, its in vitro transcription and translation assayed and its chromosomal location determined; displays useful morphogenic/mitogenic properties
08/28/2003US20030162261 7-contiguous amino acids from interleukin p40, 7-contiguous amino acids from interleukin B30, and both
08/28/2003US20030162259 Kunitz domain polypeptide zkun10
08/28/2003US20030162258 Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162247 32164 protein, a novel seven transmembrane protein
08/28/2003US20030162225 Ligands specific for an isoform of the prion protein
08/28/2003US20030162223 Detection of insecticide; determination, calibration of binding to protein
08/28/2003US20030162198 Medical diagnosis; complexing to Dna; calibration
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162191 Enzyme inhibitors; microbiocides, antiinflamamtory agents, viricides, antitumor agents; gene therapy
08/28/2003US20030162189 Adjust gene expression; genetic engineering; antiproliferative agents
08/28/2003US20030162186 Human cDNAs and proteins and uses thereof
08/28/2003US20030162177 Human Tbx20 gene and uses
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162172 Polypeptide encoding receptors; medical diagnosis; modulate gene expression
08/28/2003US20030162170 Nucleic acids; antibody, antigen complex
08/28/2003US20030161899 For prophylaxis of inhalation allergic reactions comprising mixture of saturated hydrocarbons having viscosity of greater than 6 mm2/s123n; treatment of atopic rhinitis in the form of "hayfever"
08/28/2003US20030161897 Soluble plant derived natural color concentrates and antimicrobial nutraceuticals
08/28/2003US20030161893 PTPase inhibitors and methods of using the same
08/28/2003US20030161889 Microspheres having diameter of 1 nanometer to 10 microns comprised of poly(DL-lactide-co-glycolide) as bulk matrix; immunogenic substance comprising Colony Factor Antigen or hepatitis B surface antigen
08/28/2003US20030161859 Administering insulin, mimetics or peptides to eyes for prevention/therapy of nervous systems or vision defects
08/28/2003US20030161858 Mixtures of cement powders, vitamins, hormones, antibiotics, antitumor agents, somatotropins, calcium phosphates or proteins dissolved, dispersed or emulsified in oils; bone disorders
08/28/2003US20030161850 Agent for inhibiting adhesion of the pathogenic flora of the skin
08/28/2003US20030161837 Crosslinking an immunoglobulin or fragment thereof with anN-hydroxyl-succinimide ester and a maleimide linked vis a polyethyleneoxide spacer and incubating with a polypeptide having a sulfhydryl group (an allergen or autoantigen)
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161835 Polypeptides from moraxella (branhamella) catarrhalis
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161831 Identification of polynucleotides encoding proteins having DGAT and MGAT activity, as well as the proteins encoded comprising a nucleotide sequence that has at least 50% nucleotide sequence identified; antilipemic agents
08/28/2003US20030161829 Short peptides of 12-22 amino acids from the CD-74-like domain of Insulin Growth Factor-binding protein-3 mimic the full molecule's co-apoptotic, cell-penetrating and metal-binding properties; side effects reduction; antitumor agents
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161823 Therapeutic and cosmetic uses of heparanases
08/28/2003US20030161822 Killing grampositive bacteria
08/28/2003US20030161821 Pharmaceutical composition
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161812 Using vitamin b12 compound; controlling gene expression
08/28/2003US20030161811 Method for treating cervical cancer
08/28/2003US20030161810 Methods and materials for treating inflammatory diseases
08/28/2003US20030161809 Complexes; drug delivery
08/28/2003US20030161788 System for monitoring bacterial tumor treatment
08/28/2003CA2487395A1 Method for discovering pharmacologically active substances
08/28/2003CA2485882A1 A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient
08/28/2003CA2477820A1 Polynucleotide for target gene
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476965A1 Method of modulating e-cadherin mediated cell adhesion
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476832A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003CA2476771A1 A preparation and method for weight reduction
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476711A1 Process for preparation of an inhalation powder containing a salt of the cgrp antagonist bibn4096
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003CA2476309A1 Methods and reagents for detecting target binding by nucleic acid ligands
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2473132A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
08/28/2003CA2473078A1 Method for producing interferon
1 ... 1784 1785 1786 1787 1788 1789 1790 1791 1792 1793 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 ... 3163